# The Best of Both Worlds: Integrating Language Models and Diffusion Models for Video Generation

Preprint · Aoxiong Yin, Kai Shen, Yichong Leng, Xu Tan, Xinyu Zhou, Juncheng Li, Siliang Tang

- Archive id: arxiv:2503.04606
- Published: 2025-03-06
- arXiv: https://arxiv.org/abs/2503.04606
- Source URL: https://arxiv.org/abs/2503.04606
- PDF: https://arxiv.org/pdf/2503.04606
- Provenance: arxiv

## Abstract

Recent advancements in text-to-video (T2V) generation have been driven by two competing paradigms: autoregressive language models and diffusion models. However, each paradigm has intrinsic limitations: language models struggle with visual quality and error accumulation, while diffusion models lack semantic understanding and causal modeling. In this work, we propose LanDiff, a hybrid framework that synergizes the strengths of both paradigms through coarse-to-fine generation. Our architecture introduces three key innovations: (1) a semantic tokenizer that compresses 3D visual features into compact 1D discrete representations through efficient semantic compression, achieving a $\\sim$14,000$\\times$ compression ratio; (2) a language model that generates semantic tokens with high-level semantic relationships; (3) a streaming diffusion model that refines coarse semantics into high-fidelity videos. Experiments show that LanDiff, a 5B model, achieves a score of 85.43 on the VBench T2V benchmark, surpassing the state-of-the-art open-source models Hunyuan Video (13B) and other commercial models such as Sora, Kling, and Hailuo. Furthermore, our model also achieves state-of-the-art performance in long video generation, surpassing other open-source models in this field. Our demo can be viewed at https://landiff.github.io/.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.
